Here's what to know about the peptides under discussion this week: Thursday's votes: FDA advisers largely vote in favor of reclassifying BPC-157: The votes came in 8-6, with one abstention, in favor of reclassifying BPC-157, both in free-base and acetate form
The shorter course at higher per-day dose suits patients who prefer fewer total injection days
[1] Retatrutide (trials): once-weekly subcutaneous administration, starting low (e.g., 2 mg) and escalating to 4, 8, or 12 mg maintenance, with slower titration used to improve tolerability
Particles under 50nm have even greater absorption rates and drug delivery
A.TekinS.VintersH
Glutathione is involved in maintaining cellular integrity by neutralizing reactive oxygen species that accumulate through environmental exposure, illness, physical stress, and normal aging processes